|
Search
Collections
Benchmarks
Upload document
Product
CN-Prolia®
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Healthy Male Volunteers
Clinical trial
A Randomised, Parallel, Single-Dose, Subcutaneous Injection, Phase I Clinical Study Of HLX14 Versus Prolia® (Denosumab) In Chinese Healthy Adult Male Subjects For Comparison In Pharmacokinetic Characteristics, Safety, And Immunogenicity
Status: Completed
, Estimated PCD: 2023-09-12